(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from INPI

ADMINISTRAÇÃO SUCBUTÂNEA DE ANTICORPOS ACOPLADORES DE CÉLULAS T DE LIGAÇÃO A CD19

Em AnáliseInvention PatentPCT · EP2022078638

Application data

Invention Patent ADMINISTRAÇÃO SUCBUTÂNEA DE ANTICORPOS ACOPLADORES DE CÉLULAS T DE LIGAÇÃO A CD19 de AMGEN RESEARCH (MUNICH) GMBH — IPC A61P 35/02
Invention Patent ADMINISTRAÇÃO SUCBUTÂNEA DE ANTICORPOS ACOPLADORES DE CÉLULAS T DE LIGAÇÃO A CD19 de AMGEN RESEARCH (MUNICH) GMBH — IPC A61P 35/02. Drawing published by the INPI in the Industrial Property Gazette.

Number

112024007289

Type

Invention Patent

Filing

10/14/2022

Publication

07/23/2024

PCT

EP2022078638

Progress at the INPI

  1. Filing10/14/22
  2. Publication
  3. Examination
  4. Allowance
  5. Grant
  6. In force

The application was filed at the INPI on 10/14/2022. It awaits formal examination and publication in the RPI gazette.

Leave your contact and we will alert you

We track INPI publications and let you know as soon as this case moves.

We use your details only for this alert.

Latest action published by the INPI: 07/23/2024. We update with every new RPI gazette, published weekly.

Applicants and inventors

Applicants

AMGEN RESEARCH (MUNICH) GMBH

DE

See this company's full portfolio

Inventors

G. Z. (pessoa física)

DE

Technical data

IPC Classification

Priority claims

US

63/256,056 · 10/15/2021

US

63/281,992 · 11/22/2021

Abstract

ADMINISTRAÇÃO SUCBUTÂNEA DE ANTICORPOS ACOPLADORES DE CÉLULAS T DE LIGAÇÃO A CD19. A presente invenção se relaciona em geral com a área de tratamentos médicos, particularmente com os métodos para a administração subcutânea de um anticorpo biespecífico CD19 x CD3.

Prosecution history

Publications in the Brazilian Industrial Property Gazette (RPI).

Notificação de entrada na fase nacional - PCT

#1.3

07/23/2024

RPI 2794

Alteração de dados cadastrais

#1.1

04/24/2024

RPI 2781

Patent monitoring

Track this patent in real time.

Receive alerts on INPI events, decisions, and expiry dates for your portfolio.